Medtronic Readies New CRM Products To Protect Share Taken From Guidant
This article was originally published in The Gray Sheet
Executive Summary
Medtronic is prepping three pacemakers for launch by May to compete against new products from competitor St. Jude and buttress against Guidant's potential comeback
You may also be interested in...
Medtronic paces ahead
Firm's Adapta, Versa and Sensia pacemakers offer "managed ventricular pacing" and "atrial capture management" to provide stimulation only as needed, the company said upon announcing the launch of the products. The technology has been shown to eliminate 99% of unnecessary pacing, reducing the risk of developing co-morbidities such as heart failure and atrial fibrillation, Medtronic says. The firm has been looking forward to this launch as a means of reasserting its hold on a vulnerable cardiac rhythm management market (1"The Gray Sheet" Feb. 27, 2006, p. 14)...
Medtronic paces ahead
Firm's Adapta, Versa and Sensia pacemakers offer "managed ventricular pacing" and "atrial capture management" to provide stimulation only as needed, the company said upon announcing the launch of the products. The technology has been shown to eliminate 99% of unnecessary pacing, reducing the risk of developing co-morbidities such as heart failure and atrial fibrillation, Medtronic says. The firm has been looking forward to this launch as a means of reasserting its hold on a vulnerable cardiac rhythm management market (1"The Gray Sheet" Feb. 27, 2006, p. 14)...
St. Jude Sees Future ICD Market Growth With New Treatment Paradigms
St. Jude Medical expects its next-generation Unity electronics platform for use in both implantable cardioverter defibrillators and pacemakers to impact two-thirds of all revenue going forward